Asensus Surgical, Inc. (ASXC): Analyst Median Target

Asensus Surgical, Inc. (ASXC) develops AI systems for laparoscopic surgery, competing through affordability and haptic patents. However, debt and the slow adoption of technologies by physicians hinder the path to profitability. This chart reflects the asset value on GURU.Markets at 0.35. The business is currently being integrated into the structure of a strategic owner, which has completely halted its independent expansion via mergers.

ASXC (Asensus Surgical Inc) Analyst Consensus Forecast history from 07/04/2022 to 08/31/2024

Analytical breakdowns for Asensus Surgical, Inc. (ASXC)

- stock value and consensus price forecast:

Stock Price asensus.com|ASXC - Price Target Chart

- stock exchange capitalization data:

Market Capitalization TransEnterix|ASXC - Real Price to Acquire Entire Company

- company book value details:

Equity per Share Asensus Surgical|ASXC - Book Capitalization|Market Cap to Net Assets Ratio asensus.com|ASXC - Cumulative Company Assets

- business debt structure and liquidity details:

- net income and valuation multiples indicators:

ASXC - Company Net Income|Forward Earnings Asensus Surgical, Inc.|ASXC - P/E Multiple|Projected Price to Earnings Ratio asensus.com|ASXC - Price/Earnings to Growth Multiple|EV/EBITDA Multiple TransEnterix|ASXC - Operating profit before deduction of amortization|Earnings per share for the last four quarters Asensus Surgical|ASXC - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months asensus.com|ASXC - Earnings growth in current year|Expected earnings per share growth for next year Asensus Surgical, Inc.

General company analysis:ASXC - Asensus Surgical Inc

The implementation of robotic systems by Asensus Surgical, Inc. (ASXC), which automate the work of surgical assistants, directly impacts the issuer's future cash flows and capitalization. Analysts are recalculating these expectations amid the Fed's tight monetary policy, using the price action chart to establish a consensus target equilibrium between market price and fundamental value, enabling investors to promptly identify arbitrage gaps and market inefficiencies.

Competitors of Asensus Surgical, Inc.